Property:Conflicts of interest
This is a property of type Text.
M
Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization +
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Ralph Muecke has had conference and travel expenses reimbursed and has received lecture fees from the pharmaceutical company biosyn-Arzneimittel GmbH to help run the study. +
N
Najafizade et al. (2013): Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial +
None declared +
Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients +
The authors declare no competing interest. +
Newling et al. (1995): Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group +
NI +
Ng et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial +
Listed here only in connection with Pharmavite: Dr. Ng: Grants from Pharmavite +
Nguyen et al. (2012): Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities +
According to authors no conflict of interest +
Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia +
Dr. Nangia has had a consultant/advisory role with Puma, and she has received funding from Paxman Coolers. Dr. Ade- muyiwa has had a consultant/advisory role with Immunomedics, AstraZeneca, Jounce, Eisai, and Best Doctors; she has received funding from Pfizer, Abbvie, Seattle Genetics, Immunomedics, and Polyphor. Dr. Ellis has had a consultant/advisory role with NanoString, Novartis, AstraZeneca, Pfizer, Abbvie, Sermonix, and Puma; he has stock own- ership in Bioclassifier with Royalty income from Prosigna/NanoString. Dr. Osborne has had a consultant/advisory role with Puma, AstraZeneca, and Genentech; stock ownership in GENETEX; and funding from Puma. Dr. Rimawi has had a consultant/advisory role in MacroGenics, Daiichi, and Novartis; he has received funding from Novartis and Pfizer. Dr. Ma has had a consultant/advisory role with Pfizer, Novaris, and Lilly; she has received funding from Eisai, Puma, and Pfizer. +
O
Okabayashi et al. (2020): L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients +
According to authors no conflict of interest. +
Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy +
NI +
Ota et al. (2014): The effect of pyridoxine for prevention of hand-foot-syndrome in colorectal cancer patients with adjuvant chemotherapy using capecitabine: A randomized study +
NI +
P
Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy +
NI +
"Dr. Pace has received speaker honoraria from Schering-Plough Corp. and Italfarmaco. D. Giannarelli and Dr. Galie report no disclosures. Dr. Savarese has received funding for travel and speaker honoraria from Schering-Plough Corp. Dr. Carpano, Dr. Giulia, A. Pozzi, Dr. Silvani, Dr. Gaviani, and Dr. Scaioli report no disclosures. Dr. Jandolo serves on the editorial board of Neurobiologia and the editorial advisory board of Neurological Science. Dr. Bove reports no disclosures. Dr. Cognetti has served on scientific advisory boards of Bayer Schering Pharma, Wyeth, Roche, and Sanofi-Aventis; serves as a consultant for Abbott, Wyeth, and AstraZeneca; and receives research support from the Italian National Health System." +
Panahi et al. (2012): Effect of Ginger on Acute and Delayed Chemotherapy-Induced Nausea and Vomiting: A Pilot, Randomized, Open-Label Clinical Trial +
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. +
Paur et al. (2017): Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA +
RB has interests in Vitas AS. Vitas AS was established by Oslo Innovation Center. +
Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial +
NI +
Puataweepong et. al (2009): The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: a double-blind placebo-controlled study +
NI +
According to authors no conflict of interest +
R
Raei et al. (2013): Effect of herbal therapy to intensity chemotherapy-induced nausea and vomiting in cancer patients +
None declared +
Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study +
According to authors no conflict of interest. +
Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial +
According to authors no conflict of interest +